These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 4396488)

  • 1. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    Immunology; 1971 Apr; 20(4):469-80. PubMed ID: 4396488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    Immunology; 1971 Apr; 20(4):481-92. PubMed ID: 4396489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    J Immunol; 1974 Jun; 112(6):2020-7. PubMed ID: 4151107
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological paralysis of mice with pneumococcal polysaccharide antigens.
    Halliday WJ
    Bacteriol Rev; 1971 Sep; 35(3):267-89. PubMed ID: 4398890
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-pneumococcal polysaccharide type 3 hemolytic plaques in mice: cellular response in immunity and immunologic paralysis.
    Kerman R; Segre D
    J Immunol; 1970 May; 104(5):1262-6. PubMed ID: 4392712
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.
    Baker PJ; Prescott B; Stashak PW; Amsbaugh DF
    J Immunol; 1971 Sep; 107(3):719-24. PubMed ID: 4398381
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion of type III pneumococcal polysaccharide low responders to high responders by immunization with a thymus-dependent form of antigen.
    Braley-Mullen H; Sharp GC
    Cell Immunol; 1974 Apr; 12(1):49-60. PubMed ID: 4156496
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on immunological paralysis. XI. A comparison of the tolerogenicity in vitro of levan and type 3 pneumococcal polysaccharide.
    Kotlarski I; Courtenay BM; Howard JG
    Eur J Immunol; 1973 Aug; 3(8):496-502. PubMed ID: 4148233
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B; Barth RF
    J Immunol; 1970 Dec; 105(6):1581-3. PubMed ID: 4394909
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum.
    Baker PJ; Barth RF; Stashak PW; Amsbaugh DF
    J Immunol; 1970 May; 104(5):1313-5. PubMed ID: 4392713
    [No Abstract]   [Full Text] [Related]  

  • 11. Treadmill neutralization of antibody and central inhibition. Separate components of pneumococcal polysaccharide paralysis.
    Howard JG; Christie GH; Courtenay BM
    Transplantation; 1970 Oct; 10(4):251-3. PubMed ID: 4396243
    [No Abstract]   [Full Text] [Related]  

  • 12. Requirement for lymphocyte-macrophage interaction in the response of mouse spleen cultures to pneumococcal polysaccharide.
    Aaskov JG; Halliday WJ
    Cell Immunol; 1971 Aug; 2(4):335-40. PubMed ID: 4399613
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: The basis for conflicting results obtained in studies on the plaque-forming cell response to type III pneumococcal polysaccharide.
    Baker PJ; Prescott B
    J Immunol; 1975 Sep; 115(3):891-2. PubMed ID: 239066
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased plaque-forming cell response to pneumococcal polysaccharide type 3-coated sheep erythrocytes after priming with erythrocytes but not with polysaccharide.
    Byfield P
    Cell Immunol; 1972 Apr; 3(4):616-22. PubMed ID: 4401911
    [No Abstract]   [Full Text] [Related]  

  • 15. Strain differences in the antibody plaque-forming cell responses of inbred mice to pneumococcal polysaccharide.
    Braley HC; Freeman MJ
    Cell Immunol; 1971 Feb; 2(1):73-81. PubMed ID: 4399154
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of B cell tolerance to polysaccharides by exhaustive immunization and during immunosuppression with cyclophosphamide.
    Howard JG; Courtenay BM
    Eur J Immunol; 1974 Sep; 4(9):603-8. PubMed ID: 4154200
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum.
    Warr GW; Sljivić VS
    Clin Exp Immunol; 1974 Jul; 17(3):519-32. PubMed ID: 4157122
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells.
    Jones JM; Amsbaugh DF; Stashak PW; Prescott B; Baker PJ; Alling DW
    J Immunol; 1976 Mar; 116(3):647-56. PubMed ID: 3604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic properties of the thymus-independent antigen pneumococcal polysaccharide S3.
    Coutinho A; Möller G
    Eur J Immunol; 1973 Oct; 3(10):608-13. PubMed ID: 4148779
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of antigen-specific immunologic paralysis induced by a single low dose of polyvinylpyrrolidone.
    Lake JP; Reed ND
    J Reticuloendothel Soc; 1976 Oct; 20(4):307-16. PubMed ID: 62838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.